Quick Answer
NeuroPace Inc reported Stockholders Equity of $19.03 million for fiscal year 2025.
NeuroPace Inc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $19.03M | +137.5% |
| 2024 | $8.01M | -61.2% |
| 2023 | $20.65M | -40.6% |
| 2022 | $34.78M | -52.7% |
| 2021 | $73.50M | +149.7% |
| 2020 | -$147.83M | -14.3% |
| 2019 | -$129.35M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.52M | +88.5% | -4.7% |
| June 30, 2025 | $19.44M | +96.6% | -19.9% |
| March 31, 2025 | $24.27M | +69.2% | +202.9% |
| December 31, 2024 | $8.01M | -61.2% | -18.4% |
| September 30, 2024 | $9.82M | -40.0% | -0.6% |
| June 30, 2024 | $9.88M | -53.4% | -31.1% |
| March 31, 2024 | $14.34M | -47.8% | -30.6% |
| December 31, 2023 | $20.65M | -40.6% | +26.2% |
- NeuroPace Inc showed an increase of +137.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, NeuroPace Inc’s stockholders equity has grown by 114.7% (from -$129.35 million to $19.03 million).
- The most recent figure is from NeuroPace Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: